These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 19607926

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.
    Jauhiainen AM, Pihlajamäki M, Tervo S, Niskanen E, Tanila H, Hänninen T, Vanninen RL, Soininen H.
    Hippocampus; 2009 Feb; 19(2):166-75. PubMed ID: 18777563
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP.
    Neurosci Lett; 2009 Feb; 384(1-2):23-8. PubMed ID: 15905028
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment.
    Fellgiebel A, Müller MJ, Wille P, Dellani PR, Scheurich A, Schmidt LG, Stoeter P.
    Neurobiol Aging; 2005 Feb; 26(8):1193-8. PubMed ID: 15917103
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Goekoop R, Scheltens P, Barkhof F, Rombouts SA.
    Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of Alzheimer's disease.
    Uotani C, Sugimori K, Kobayashi K.
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):319-26. PubMed ID: 16732748
    [Abstract] [Full Text] [Related]

  • 13. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
    Meyer JS, Huang J, Chowdhury MH.
    J Neurol Sci; 2007 Jun 15; 257(1-2):97-104. PubMed ID: 17316690
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M, Sinervä E, Grönholm P, Rinne J, Laine M.
    Acta Neurol Scand; 2005 Mar 15; 111(3):172-9. PubMed ID: 15691286
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Mild Cognitive Impairment or pre-demential Alzheimer's disease?].
    Sarazin M, Dubois B.
    Rev Neurol (Paris); 2002 Mar 15; 158(10 Suppl):S30-4. PubMed ID: 12529583
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD.
    deToledo-Morrell L, Stoub TR, Bulgakova M, Wilson RS, Bennett DA, Leurgans S, Wuu J, Turner DA.
    Neurobiol Aging; 2004 Oct 15; 25(9):1197-203. PubMed ID: 15312965
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.